Drug intelligence / Profile preview

Pylee

Development stage: Unknown
Lead developer: Juvenor Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

Pylee is an oral phytomedicine developed by Juvenor Pharmaceuticals and marketed in collaboration with Piramal Enterprises. It is an approved Ayurvedic formulation indicated for the management of hemorrhoids (piles). The product is designed to provide symptomatic relief from pain, itching, and bleeding associated with anorectal conditions. As a phytomedicine, it utilizes a combination of plant-derived active ingredients that typically exhibit anti-inflammatory, wound-healing, and mild laxative properties to improve venous tone and facilitate easier bowel movements.

Brand names: Pylee

Beyond the preview

Go deeper on Pylee.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pylee.

Explore the full profile